Cite
HARVARD Citation
Zhang, Z. et al. (2020). Adding vitamin D3 to the dipeptidyl peptidase‐4 inhibitor saxagliptin has the potential to protect β‐cell function in LADA patients: A 1‐year pilot study. Diabetes/metabolism research and reviews. 36 (5), p. n/a. [Online].